Molecular Data Alpha and Beta Analysis
| MKDTYDelisted Stock | USD 0.01 0.01 2,567% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Molecular Data. It also helps investors analyze the systematic and unsystematic risks associated with investing in Molecular Data over a specified time horizon. Remember, high Molecular Data's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Molecular Data's market risk premium analysis include:
Beta (8.30) | Alpha 45.16 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Molecular |
Molecular Data Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Molecular Data market risk premium is the additional return an investor will receive from holding Molecular Data long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Molecular Data. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Molecular Data's performance over market.| α | 45.16 | β | -8.3 |
Molecular Data Fundamentals Vs Peers
Comparing Molecular Data's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Molecular Data's direct or indirect competition across all of the common fundamentals between Molecular Data and the related equities. This way, we can detect undervalued stocks with similar characteristics as Molecular Data or determine the pink sheets which would be an excellent addition to an existing portfolio. Peer analysis of Molecular Data's fundamental indicators could also be used in its relative valuation, which is a method of valuing Molecular Data by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Molecular Data to competition |
| Fundamentals | Molecular Data | Peer Average |
| Number Of Employees | 189 | 18.84 K |
Molecular Data Opportunities
Molecular Data Return and Market Media
The Stock did not receive any noticable media coverage during the period. Price Growth (%) |
| Timeline |
About Molecular Data Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Molecular or other pink sheets. Alpha measures the amount that position in Molecular Data has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Molecular Data in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Molecular Data's short interest history, or implied volatility extrapolated from Molecular Data options trading.
Build Portfolio with Molecular Data
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Consideration for investing in Molecular Pink Sheet
If you are still planning to invest in Molecular Data check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Molecular Data's history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stocks Directory Find actively traded stocks across global markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |